Analysis of tracheostomies in a Paediatric Intensive Care Unit during the period 2003–2013

Autor: García-Urabayen, D., López-Fernández, Y.M., Pilar-Orive, J., Nieto-Faza, M., Gil-Antón, J., López-Bayón, J., Redondo-Blázquez, S.

Publikováno v: In Anales de Pediatría (English Edition) January 2016 84(1):18-23

Oxigenoterapia de alto flujo: el soporte respiratorio no invasivo sale de la UCIP. Es una alternativa eficiente?

Autor: Pilar Orive J, Modesto I Alapont V

Publikováno v: ANALES DE PEDIATRIA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9deb0646f52237e528ca5fdfdc9fbec6
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10335

Tratamiento de la taquicardia ectópica de la unión tras la cirugía

Autor: Cabrera Duro, A., Rodrigo Carbonero, D., Macua Biurrun, P., Martínez Corrales, P., Pastor Menchaca, E., Galdeano Miranda, J.M., Pilar Orive, J.

Publikováno v: In Anales de Pediatria 2002 56(6):505-509

[High-flow oxygen therapy: Non-invasive respiratory support goes out of the PICU. Is it an efficient alternative?]

Autor: Pilar Orive J; Unidad de Cuidados Intensivos Pediátricos, Hospital Universitario de Cruces, Barakaldo, Vizcaya, España., Modesto I Alapont V; Unidad de Cuidados Intensivos Pediátricos,, Hospital Universitari i Politècnic La Fe, València, España. Electronic address: vicent.modesto@gamil.com.

Publikováno v: Anales de pediatria [An Pediatr (Engl Ed)] 2019 Feb; Vol. 90 (2), pp. 69-71. Date of Electronic Publication: 2018 Dec 31.

Identification of a panel of serum protein markers in early stage of sepsis and its validation in a cohort of patients.

Autor: Garcia-Obregon S; Pediatric Oncology Group, BioCruces Health Research Institute, 48903, Barakaldo, Spain. Electronic address: susana.garciaobregon@osakidetza.eus., Azkargorta M; Proteomics Platform, CIC bioGUNE, CIBERehd, ProteoRed-ISCIII, Bizkaia Science and Technology Park, 48160, Derio, Spain., Seijas I; Pediatric Oncology Group, BioCruces Health Research Institute, 48903, Barakaldo, Spain; Intensive Care Service, Hospital Universitario Cruces, 48903, Barakaldo, Spain., Pilar-Orive J; Pediatric Critical Care Group, BioCruces Health Research Institute, 48903, Barakaldo, Spain; Pediatric Critical Care Service, Hospital Universitario Cruces, 48903, Barakaldo, Spain., Borrego F; Immunopathology Group, BioCruces Health Research Institute, 48903, Barakaldo, Spain; Ikerbasque, Basque Foundation for Science, 48013, Bilbao, Spain., Elortza F; Proteomics Platform, CIC bioGUNE, CIBERehd, ProteoRed-ISCIII, Bizkaia Science and Technology Park, 48160, Derio, Spain., Boyano MD; Tumor Markers and Chemoresistance Group, BioCruces Health Research Institute, 48903, Barakaldo, Spain; Department of Cell Biology and Histology, Faculty of Medicine, University of the Basque Country, UPV/EHU, Leioa, 48940, Bizkaia, Spain., Astigarraga I; Pediatric Oncology Group, BioCruces Health Research Institute, 48903, Barakaldo, Spain; Pediatric Service, Hospital Universitario Cruces, 48903, Barakaldo, Spain; Department of Pediatric, Faculty of Medicine, University of the Basque Country, UPV/EHU, Leioa, 48940, Bizkaia, Spain.

Publikováno v: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2018 Aug; Vol. 51 (4), pp. 465-472. Date of Electronic Publication: 2017 Jun 13.